These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10527879)

  • 21. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
    Azad AA
    Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proline 35 of human immunodeficiency virus type 1 (HIV-1) Vpr regulates the integrity of the N-terminal helix and the incorporation of Vpr into virus particles and supports the replication of R5-tropic HIV-1 in human lymphoid tissue ex vivo.
    Votteler J; Studtrucker N; Sörgel S; Münch J; Rücker E; Kirchhoff F; Schick B; Henklein P; Fossen T; Bruns K; Sharma A; Wray V; Schubert U
    J Virol; 2007 Sep; 81(17):9572-6. PubMed ID: 17553868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells.
    Bolton DL; Lenardo MJ
    J Virol; 2007 Sep; 81(17):8878-90. PubMed ID: 17553871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The human immunodeficiency virus Vpr protein binds Cdc25C: implications for G2 arrest.
    Goh WC; Manel N; Emerman M
    Virology; 2004 Jan; 318(1):337-49. PubMed ID: 14972559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular addition of a domain of HIV-1 Vpr containing the amino acid sequence motif H(S/F)RIG causes cell membrane permeabilization and death.
    Macreadie IG; Arunagiri CK; Hewish DR; White JF; Azad AA
    Mol Microbiol; 1996 Mar; 19(6):1185-92. PubMed ID: 8730861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel inducible expression system to study transdominant mutants of HIV-1 Vpr.
    Zhou Y; Ratner L
    Virology; 2001 Aug; 287(1):133-42. PubMed ID: 11504548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of M-phase arrest and apoptosis after HIV-1 Vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells.
    Watanabe N; Yamaguchi T; Akimoto Y; Rattner JB; Hirano H; Nakauchi H
    Exp Cell Res; 2000 Aug; 258(2):261-9. PubMed ID: 10896777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of a human DNA repair protein UBA domain that interacts with HIV-1 Vpr.
    Dieckmann T; Withers-Ward ES; Jarosinski MA; Liu CF; Chen IS; Feigon J
    Nat Struct Biol; 1998 Dec; 5(12):1042-7. PubMed ID: 9846873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.
    Yao XJ; Subbramanian RA; Rougeau N; Boisvert F; Bergeron D; Cohen EA
    J Virol; 1995 Nov; 69(11):7032-44. PubMed ID: 7474123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC.
    Qiao H; McMillan JR
    FEBS Lett; 2007 Feb; 581(3):535-40. PubMed ID: 17254575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of protein phosphatase-2A1 by HIV-1 Vpr cell death causing peptide in intact CD(4+) T cells and in vitro.
    Janoo A; Morrow PW; Tung HY
    J Cell Biochem; 2005 Mar; 94(4):816-25. PubMed ID: 15578586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.
    Mahalingam S; Ayyavoo V; Patel M; Kieber-Emmons T; Weiner DB
    J Virol; 1997 Sep; 71(9):6339-47. PubMed ID: 9261351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain.
    Bourbigot S; Beltz H; Denis J; Morellet N; Roques BP; Mély Y; Bouaziz S
    Biochem J; 2005 Apr; 387(Pt 2):333-41. PubMed ID: 15571493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus vpr gene encodes a virion-associated protein.
    Yuan X; Matsuda Z; Matsuda M; Essex M; Lee TH
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1265-71. PubMed ID: 2150318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr.
    Mansky LM; Preveral S; Le Rouzic E; Bernard LC; Selig L; Depienne C; Benarous R; Benichou S
    Virology; 2001 Mar; 282(1):176-85. PubMed ID: 11259200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae.
    Macreadie IG; Thorburn DR; Kirby DM; Castelli LA; de Rozario NL; Azad AA
    FEBS Lett; 1997 Jun; 410(2-3):145-9. PubMed ID: 9237618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1.
    Wang L; Mukherjee S; Narayan O; Zhao LJ
    Gene; 1996 Oct; 178(1-2):7-13. PubMed ID: 8921884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity.
    Watanabe N; Nishihara Y; Yamaguchi T; Koito A; Miyoshi H; Kakeya H; Osada H
    FEBS Lett; 2006 May; 580(11):2598-602. PubMed ID: 16631749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.